Literature DB >> 33623525

18F-prostate-specific membrane antigen positron emission tomography computed tomography incidental finding in a patient after COVID-19 infection.

Siroos Mirzaei1, Cherin Farhan1, Mario Karolyi2.   

Abstract

The COVID-19 pandemic has now reached most countries. However, the referred patients to a nuclear medicine department will be primarily the asymptomatic ones. We report the case of a patient (84-year-old male) who was sent for18F-prostate-specific membrane antigen positron emission tomography computed tomography (PSMA PET-CT) with suspicion of recurrent disease after prostate cancer and total prostatectomy 2 years prior to the examination. He suffered from COVID-19 pneumonia 4 weeks prior to PET-CT examination. The18F-PSMA PET-CT revealed moderate elevated uptake in the area of previous pneumonia in the right lung. The radiological findings showed ground glass changes in this area indicating possible residual inflammatory disease even weeks after infection. Copyright:
© 2020 World Journal of Nuclear Medicine.

Entities:  

Keywords:  18F-prostate-specific membrane antigen; COVID-19; infection; positron emission tomography computed tomography; prostate cancer

Year:  2020        PMID: 33623525      PMCID: PMC7875034          DOI: 10.4103/wjnm.WJNM_110_20

Source DB:  PubMed          Journal:  World J Nucl Med        ISSN: 1450-1147


  5 in total

1.  Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences.

Authors:  Johannes Czernin; Stefano Fanti; Philipp T Meyer; Martin Allen-Auerbach; Marcus Hacker; Mike Sathekge; Rodney Hicks; Andrew M Scott; Jun Hatazawa; Mijin Yun; Heiko Schöder; Peter Bartenstein; Ken Herrmann
Journal:  J Nucl Med       Date:  2020-04-01       Impact factor: 10.057

2.  64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies.

Authors:  Bernhard Grubmüller; Richard P Baum; Enza Capasso; Aviral Singh; Yasaman Ahmadi; Peter Knoll; Andreas Floth; Sergio Righi; Shahin Zandieh; Carlo Meleddu; Shahrokh F Shariat; Hans Christoph Klingler; Siroos Mirzaei
Journal:  Cancer Biother Radiopharm       Date:  2016-10-07       Impact factor: 3.099

3.  Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.

Authors:  Ehsan Sharif-Paghaleh; May Lin Yap; Sarah-Lena Puhl; Adam Badar; Julia Baguña Torres; Krisanat Chuamsaamarkkee; Florian Kampmeier; Richard A Smith; James Clark; Philip J Blower; Steven Sacks; Gregory E Mullen
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

4.  FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients.

Authors:  Lucia Setti; Margarita Kirienko; Serena Camilla Dalto; Manuela Bonacina; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-27       Impact factor: 9.236

5.  COVID-19 pandemic: guidance for nuclear medicine departments.

Authors:  D Paez; G Gnanasegaran; S Fanti; J Bomanji; M Hacker; M Sathekge; H S Bom; J J Cerci; A Chiti; K Herrmann; A M Scott; J Czernin; N El-Haj; E Estrada; O Pellet; P Orellana; F Giammarile; M Abdel-Wahab
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.